NCT02390921View on ClinicalTrials.gov

The Use of Liposomated Iron After Bariatric Surgery in Patients That Are Receiving Parentheral Therapy With Iron

PHASE4CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

February 28, 2015

Primary Completion Date

October 31, 2015

Study Completion Date

November 30, 2015

Conditions
Liposomated IronY-de-Roux Gastric By-PassParenteral Iron Therapy
Interventions
DRUG

Fisiogen Ferro Forte

The patients will interrupt the endovenous treatment with iron and will receive liposomated iron 28mg/daily during 3 months.

DRUG

Venofer

The patients will continue their usual endovenous administration of Venofer 300mg every 3 month

Trial Locations (1)

08035

Hospital Universitari Vall d'Hebron, Barcelona

All Listed Sponsors
lead

Hospital Universitari Vall d'Hebron Research Institute

OTHER

NCT02390921 - The Use of Liposomated Iron After Bariatric Surgery in Patients That Are Receiving Parentheral Therapy With Iron | Biotech Hunter | Biotech Hunter